Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Restrictive cardiomyopathies]

C Rapezzi1, P Ortolani, A M Traini

  • 1Istituto di Malattie dell'Apparato Cardiovascolare, Università degli Studi, Bologna.

Cardiologia (Rome, Italy)
|December 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Same author

Stable and unstable angina pectoris.

Platelets·2010
Same author

Changes in exercise capacity induced by heart transplantation: prognostic and therapeutic implications.

Scandinavian journal of medicine & science in sports·2010
Same author

Expenditure and value for money: the challenge of implantable cardioverter defibrillators.

QJM : monthly journal of the Association of Physicians·2009
Same author

Pharmacological treatment of atrial fibrillation: a review on prevention of recurrences and control of ventricular response.

Archives of gerontology and geriatrics·2008
Same author

Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality.

Heart (British Cardiac Society)·2008
Same journal

[Prevention in coronary postangioplasty restenosis with omega-3 fatty acids. Results of the Italian study on prevention of restenosis with esapent (ESPRIT)].

Cardiologia (Rome, Italy)·2002
Same journal

[Results of GISSI Prevenzione: diet, drugs, and cardiovascular risk. Researchers of GISSI Prevenzione].

Cardiologia (Rome, Italy)·2002
Same journal

[New therapeutic strategies in heart failure. Which patients need defibrillation backup?].

Cardiologia (Rome, Italy)·2002
Same journal

[Electromechanical re-synchronization with sequential heart stimulation as a new non-pharmacologic treatment of advanced heart failure. Physiopathologic features and clinical results].

Cardiologia (Rome, Italy)·2002
Same journal

[New therapeutic strategies in heart failure. Pharmacologic therapy].

Cardiologia (Rome, Italy)·2002
Same journal

[Genetics as a guide for antihypertensive therapy: future perspectives].

Cardiologia (Rome, Italy)·2002
See all related articles

Restrictive cardiomyopathies, including endomyocardial fibrosis and Loeffler endocarditis, are rare. Idiopathic restrictive cardiomyopathy is now the most frequent type in Western countries, necessitating a classification revision.

Area of Science:

  • Cardiology
  • Pathophysiology
  • Medical Classification

Context:

  • Restrictive cardiomyopathies are the least common of the three major categories of cardiomyopathic disorders in Western countries.
  • The WHO/ISFC Task Force defines restrictive cardiomyopathy to include only endomyocardial fibrosis and Loeffler endocarditis.
  • Many myocardial diseases can exhibit a restrictive pathophysiologic profile.

Purpose:

  • To review recent advances in understanding restrictive cardiomyopathies.
  • To highlight the identification of a common pathophysiology linking Loeffler endocarditis and endomyocardial fibrosis.
  • To discuss the emergence and definition of idiopathic restrictive cardiomyopathy.

Summary:

  • Recent research has identified a shared pathophysiology between Loeffler endocarditis and endomyocardial fibrosis.

Related Experiment Videos

  • Idiopathic restrictive cardiomyopathy, characterized by restrictive physiology of unknown etiology and no infiltrative/storage disease evidence, is increasingly recognized.
  • This condition is now the most frequent type of restrictive cardiomyopathy in Western populations.

    • Impact:

    • The findings necessitate a revision of the current classification of cardiomyopathies, particularly restrictive myocardial disease.
    • Improved understanding may lead to more accurate diagnosis and tailored treatment strategies for restrictive cardiomyopathies.
    • This work emphasizes the need for updated diagnostic criteria and further etiological research into idiopathic restrictive cardiomyopathy.